VCM
UTHR icon

Voleon Capital Management’s United Therapeutics UTHR Stock Holding History

Voleon Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.14M Buy
7,649
+4,544
+146% +$2.56M 0.08% 247
2026
Q1 		$1.84M Sell
3,105
-4,878
-61% -$2.43M 0.04% 345
2025
Q4 		$3.89M Buy
7,983
+6,654
+501% +$3.1M 0.08% 231
2025
Q3 		$557K Buy
+1,329
New +$447K 0.01% 551
2019
Q3 		– Sell
-42,000
Closed -$3.28M – 242
2019
Q2 		$3.28M Buy
+42,000
New +$3.93M 0.19% 96

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Voleon Capital Management's UTHR Position: Q2 2026 in Review

Voleon Capital Management increased its United Therapeutics (UTHR) stake by 146% in Q2 2026, buying an estimated $2.56M and bringing the position to 7,649 shares worth $4.14M. The position accounts for 0.08% of the portfolio, ranked #247.

Voleon Capital Management first reported a position in UTHR in Q2 2019 and has held it in 5 quarters since. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Voleon Capital Management held 7,649 shares of United Therapeutics worth $4.14M as of Q2 2026.
  • Voleon Capital Management bought 4,544 United Therapeutics shares in Q2 2026, an estimated $2.56M.
  • United Therapeutics made up 0.08% of Voleon Capital Management's portfolio in Q2 2026, its #247 holding.
  • Voleon Capital Management first reported a position in United Therapeutics in Q2 2019 and has held it in 5 quarters since.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.